Targeted and Immune-Based Therapies for Acute Myeloid Leukemia: Inflammatory Signaling and Multiple Post-Translational Modifications.

Targeted and Immune-Based Therapies for Acute Myeloid Leukemia: Inflammatory Signaling and Multiple Post-Translational Modifications. Curr Med Chem. 2019;26(28):5242-5243 Authors: Selheim F PMID: 31721689 [PubMed - in process]

https://www.ncbi.nlm.nih.gov/pubmed/31721689?dopt=Abstract

Source: Current Medicinal Chemistry - November 14, 2019 Category: Chemistry Authors: Selheim F Tags: Curr Med Chem Source Type: research

More News: Acute Leukemia | Acute Myeloid Leukemia | Chemistry | Leukemia